Monday, November 23, 2020

Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL

Cancer shared this article with you from Inoreader
Condition:   Lymphoma, Non-Hodgkin Intervention:   Biological: anti-CD19 FasT CAR-T cells Sponsors:   Xinqiao Hospital of Chongqing;   Gracell Biotechnologies (Shanghai) Co., Ltd;   920th Hospital of Joint Logistics Support Force;   The Second Affiliated Hospital of Chongqing Medical University;   The Affiliated Hospital Of Guizhou Medical University;   The Second Affiliated Ho spital of Kunming Medical University;   Chongqing University Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
View on the web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...